MEDTR.E — Meditera Tibbi Malzeme Sanayi ve Ticaret AS Income Statement
0.000.00%
Last trade - 00:00- TRY3.94bn
- TRY3.61bn
- TRY1.45bn
- 82
- 27
- 28
- 39
Annual income statement for Meditera Tibbi Malzeme Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 232 | 359 | 376 | 1,596 | 1,452 |
| Cost of Revenue | |||||
| Gross Profit | 92.3 | 164 | 166 | 681 | 644 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 196 | 265 | 296 | 1,214 | 1,183 |
| Operating Profit | 36.3 | 94.1 | 80.2 | 382 | 270 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 32.1 | 65.1 | 202 | 196 | 55.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 27.2 | 60.4 | 168 | 114 | 25.9 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 12.7 | 60.4 | 168 | 114 | 25.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 12.7 | 60.4 | 168 | 114 | 25.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.109 | 0.51 | 1.4 | 0.911 | -0.254 |
| Dividends per Share |